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ABSTRACT Penetratin is a short, basic cell-penetrating peptide able to induce cellular uptake of a vast variety of large, hydro-
philic cargos. We have reassessed the highly controversial issue of direct permeation of the strongly cationic peptide across
negatively charged lipid membranes. Confocal laser scanning microscopy on rhodamine-labeled giant vesicles incubated with
carboxyﬂuorescein-labeled penetratin yielded no evidence of transbilayer movement, in contradiction to previously reported
results. Confocal ﬂuorescence spectroscopy on black lipid membranes conﬁrmed this ﬁnding, which was also not affected by
application of a transmembrane electric potential difference. A novel dialysis assay based on tryptophan absorbance and
ﬂuorescence spectroscopy demonstrated that the permeability of small and large unilamellar vesicles to penetratin is,1013 m/s.
Taken together, the results show that penetratin is not capable of overcomingmodel membrane systems irrespective of the bilayer
curvature or the presence of a transmembrane voltage. Thus, direct translocation across the hydrophobic core of the plasma
membrane cannot account for the efﬁcient uptake of penetratin into live cells, which is in accord with recent in vitro studies
underlining the importance of endocytosis in the internalization process of cationic cell-penetrating peptides.
INTRODUCTION
Penetratin (pAntp) is a 16-amino acid peptide with the se-
quence RQIKIWFQNRRMKWKK. It corresponds to the third
helix (residues 43–58) of the homeodomain of the Anten-
napedia homeoprotein, a key transcription factor in the devel-
opment ofDrosophila (1). The short, basic sequencemediates
efﬁcient cellular internalization of the homeodomain and has
also been shown to convey other large, hydrophilic entities
into the cell interior (2). It therefore belongs to the group of so-
called cell-penetrating peptides (CPPs), a diverse class of
short, water-soluble peptides able to translocate and transport
cargo across cell membranes with low toxicity (3). Coupling
of CPPs to proteins, oligonucleotides, peptide nucleic acids,
and other pharmacologically interesting compounds thus
provides a promising strategy for cellular delivery of other-
wise membrane-impermeant molecules (4,5).
Initial observations suggested that cellular internalization
and nuclear localization of penetratin are energy- and receptor-
independent, not saturable, and not impeded by low tempera-
ture (4C), arguing against endocytosis as the dominating
uptake mechanism (6,7). This seemed to be in agreement
with studies on artiﬁcial vesicles, which supported direct
permeation of penetratin across lipid membranes without
permeabilization (8,9). More recently, harsh cell ﬁxation
before microscopy and insufﬁcient washing before ﬂow cyto-
metry have been determined to be responsible for artifactual
cellular uptake in the early in vitro experiments (10,11), and
it is nowadays widely accepted that endocytotic processes
play a major role in the translocation of penetratin and pene-
tratin/cargo complexes (12–14).
However, the question as to whether penetratin permeates
a pure lipid bilayer without causing membrane permeabili-
zation has remained a debatable and puzzling one because a
prohibitively high Born charging energy is expected to
hamper passive diffusion of a molecule with a nominal charge
number of znom ¼ 7 across a medium of low dielectricity.
Whereas ﬂuorescence microscopic studies with giant vesicles
(GVs) seemingly unveiled that penetratin rapidly overcomes
lipid bilayers (8), no permeation across the membranes of
small and large unilamellar vesicles (SUVs and LUVs,
respectively) could be detected by ﬂuorescence resonance
energy transfer (15,16). Others have speculated that a trans-
bilayer voltage might be necessary for triggering transloca-
tion (17,18). The discrepancies between these results have
been attributed to differences in experimental conditions,
most notably in size and bilayer curvature of the various lipid
vesicles used (16).
This led us to resume a systematic assessment of penetratin
transport through diverse model membranes with a variety of
experimental techniques. We reevaluated the ability of
penetratin to translocate across the lipid bilayers of different
types of liposomes (GVs, SUVs, and LUVs) and black lipid
membranes in the absence or presence of an electric potential
difference. Confocal laser scanning microscopy (CLSM)
was used to follow the distribution of carboxyﬂuorescein-
labeled penetratin interacting with rhodamine-labeled GVs,
and the inﬂuence of a transmembrane potential difference on
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the permeability of a planar lipid bilayer was probed with
confocal ﬂuorescence spectroscopy. By subjecting differently
prepared solutions containing penetratin and SUVs or LUVs
to dialysis, we established a new method for monitoring mem-
brane permeation. All our experiments consistently demon-
strate that, under the conditions used here, penetratin does not
cross any of these lipid barriers regardless of bilayer curvature
and transmembrane voltage.
MATERIALS AND METHODS
Materials
The lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC),
1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (POPG, so-
dium salt), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[lissamine
rhodamine B sulfonyl] (Rh-DPPE, ammonium salt), 1,2-diphytanoyl-sn-
glycero-3-phosphocholine (DPhPC), and 1,2-diphytanoyl-sn-glycero-3-[phos-
pho-L-serine] (DPhPS, sodium salt) were purchased from Avanti Polar
Lipids (Alabaster, AL). Hexane was from Fluka (Buchs, Switzerland) and
5(6)-carboxyﬂuorescein-N-hydroxysuccinimide ester (FLUOS) from Boeh-
ringer Mannheim (Mannheim, Germany). Glucose, sucrose, and ﬂuorescein
diacetate were obtained from Sigma (Deisenhof, Germany) and all other
chemicals from Merck (Darmstadt, Germany).
Peptide synthesis
Peptides were synthesized automatically on an ABI 433A instrument
(Applied Biosystems, Foster City, CA) following the standard solid-phase
Na-9-ﬂuorenylmethoxycarbonyl protocol in a batchwise mode as described
previously (19). A carboxyﬂuorescein-labeled derivative (CF-penetratin)
was prepared by N-terminal coupling of FLUOS and C-terminal amidation
to conserve the net charge of the peptide. Both analogs were puriﬁed by
preparative reversed-phase high-performance liquid chromatography on an
LC-10AD system (Shimadzu, Kyoto, Japan) operating at 220 nm. The
purities of the ﬁnal products were .98% by analytical high-performance
liquid chromatography, and their expected molar masses were conﬁrmed by
matrix-assisted laser desorption/ionization time-of-ﬂight mass spectrometry
on a Voyager-DE STR (Applied Biosystems).
Confocal microscopy with giant vesicles
Sample preparation
Giant vesicles were prepared by the spontaneous-formation method (20).
Brieﬂy, 1 mg POPC/POPG (3:1 mol/mol) and 0.1 mg Rh-DPPE (0.0061 mol %),
all dissolved in chloroform at 20 mg/mL for the unlabeled and 1 mg/mL for
the labeled lipids, respectively, were mixed in a 10-mL sample tube and
dried in a rotary evaporator and subsequently under high vacuum overnight.
The dried lipid ﬁlm was prehydrated at 40C and 100% relative humidity for
1 h in an argon atmosphere before addition of 5 mL internal medium (pH
;5.9) consisting of 100 mM sucrose, 10 mM KCl, and 0.1 mM ethylene-
diaminetetraacetate (EDTA). During overnight incubation at 37C, vesicles
formed and gathered in a viscous cloud, which was harvested with a Pasteur
pipette. The lipid concentration was determined with a phosphate assay (21).
The vesicle solution was diluted with external medium (pH ;5.5) con-
taining 100 mM glucose, 10 mM KCl, and 0.1 mM EDTA to a lipid concen-
tration of 200 mM. Water-dissolved CF-penetratin was added to give a ﬁnal
peptide concentration of 5 mM.
Confocal laser scanning microscopy
After gentle vortex mixing, an aliquot of the penetratin/GVmixture was placed
onto a window of a two-part quartz cuvette (Hellma, Mu¨llheim, Germany)
with a pathlength of 0.1 mm and covered with a coverslip. The density
difference between the internal and the external medium made the vesicles
settle down on the bottom of the cuvette, which was mounted in a homemade
holder. CLSM pictures were taken within 4 h after preparation on an LSM
510 META microscope equipped with an LD Achroplan 403/0.60 corr.
objective, a helium/neon laser with a dichroitic HTF mirror, and an argon
laser with a DPS1 mirror (Carl Zeiss, Jena, Germany). Upon excitation at
543 nm with the He/Ne laser, rhodamine emission was registered using an
LP 560 cutoff ﬁlter in front of the detector at a signal ampliﬁcation of 18%.
Carboxyﬂuorescein was excited at 488 nm with the argon laser, and CLSM
images were taken with a BP 505–530 bandpass ﬁlter at an ampliﬁcation of
74%. The pinhole width was 249 mm for both channels.
Confocal spectroscopy with black
lipid membranes
Sample preparation
Black lipid membranes (22) were generated in a homemade Teﬂon trough
(23) divided into two compartments by a horizontal polytetraﬂuoroethylene
(PTFE) membrane (Goodfellow, Cambridge, United Kingdom). The upper
(cis, c) and the lower (trans, t) chambers were ﬁlled with 500 mL and 2 mL
buffer, respectively. A planar lipid bilayer consisting of DPhPC/DPhPS (3:1
mol/mol) was formed by brushing a droplet of the lipid mixture dissolved in
n-decane at 20 mg/mL onto the 150-mm-diameter hole in the PTFE septum,
which was pretreated with hexadecane/hexane (1:99 v/v). Ag/AgCl elec-
trodes positioned in both compartments allowed for the application of an
electric potential difference, Df[ ft –fc. The voltage and the electric current
across the lipid bilayer were controlled simultaneously using an EPC-9
patch-clamp ampliﬁer (HEKA Electronics, Lambrecht, Germany) to make
sure that the membrane stayed intact during the experiment. For studying
bilayer translocation of penetratin, both chambers were ﬁlled with 10 mM
phosphate buffer (pH 7.4, 154 mM NaCl). After formation of the black lipid
membrane, 5 mL 100 mM CF-penetratin was added to the upper compart-
ment to yield a ﬁnal peptide concentration of 1 mM.
Control experiment
Experiments with ﬂuorescein diacetate as a positive control were done to
ensure the suitability of the experimental setup for detecting transmembrane
transport. An aliquot of a freshly prepared solution of 10 mM ﬂuorescein
diacetate in dimethyl sulphoxide was added to the upper compartment to
give a ﬁnal concentration of 20 mM. The experimental conditions were the
same as for CF-penetratin, except that the pH was adjusted to 8.0 to speed up
hydrolysis. The nonﬂuorescent ﬂuorescein diacetate is known to diffuse
across lipid membranes as long as it is kept in its unhydrolyzed form (24).
Hydrolysis yields the bilayer-impermeant ﬂuorophore ﬂuorescein.
Confocal ﬂuorescence spectroscopy
The distribution of CF-penetratin or ﬂuorescein between the two compart-
ments was monitored using an LSM 510 META inverted confocal laser
scanning microscope equipped with a ConfoCor 2 unit (Carl Zeiss). The
ﬂuorophores were excited at 488 nm, and the emitted light was ﬁltered with an
LP 505 longpass ﬁlter in front of the avalanche photodiode detector. The
ﬂuorescence intensity, I, was scanned bymoving the confocal volume of 0.7 fL
vertically (i.e., in z direction) through both compartments with a stepwidth of
1 mm. The confocal volume was then ﬁxed at a distance of 25 mm above or
below the planar membrane, respectively, to record ﬂuctuations in ﬂuo-
rescence intensity, from which normalized autocorrelation functions, G(t),
were derived using the ConfoCor 2 software provided by the manufacturer.
For a single diffusing species (25), the autocorrelation function is given by
GðtÞ ¼ 11 1
N
1
11 t=tD
 
1
11 t=ðv2tDÞ
 1=2
; (1)
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where tD is the characteristic diffusion time of the ﬂuorophore in the prolate
ellipsoidal Gaussian observation volume with a ratio of the axial to the lateral
dimension of v ¼ 5. The confocal volume was calibrated with a solution
of rhodamine green. N stands for the mean number of ﬂuorescent particles in
the confocal volume and thus yields the concentration of CF-penetratin or
ﬂuorescein.
Dialysis with small and large unilamellar vesicles
Sample preparation
POPC and POPG dissolved in chloroform at 20 mg/mL were mixed in
a molar ratio of 3:1 and dried in a rotary evaporator and subsequently under
high vacuum overnight. For the preparation of pure lipid vesicles, dry lipid
ﬁlms were suspended in 10 mM phosphate buffer (pH 7.4, 154 mM NaF) by
vortex mixing for 5 min, yielding large multilamellar vesicles. Bilayers
preloaded with penetratin on both leaﬂets were made in the same manner by
suspending lipid ﬁlms in buffer containing the peptide at the desired ﬁnal
concentration of 25 mM. SUVs were then obtained by ultrasonication in
an ice/water bath for 20 min with a Labsonic L instrument (B. Braun,
Melsungen, Germany) equipped with a titanium tip, followed by spinning
for 5 min at 13 krpm in a 3K30 tabletop centrifuge (Sigma Laborzentrifugen,
Osterode am Harz, Germany) to remove titanium debris. LUVs were
prepared by 35 extrusion steps through two stacked polycarbonate ﬁlters
with a pore diameter of 100 nm using a LiposoFast extruder (Avestin,
Ottawa, Canada). The vesicle size was checked on an N4 Plus particle sizer
(Beckman Coulter, Fullerton, CA) equipped with a 10-mW helium/neon
laser with a wavelength of 632.8 nm at a scattering angle of 90 and was
narrowly centered at ;30 nm for SUVs and ;100 nm for LUVs,
respectively. The presence of penetratin during vesicle formation had no
effect on the size of the liposomes. The excess of lipid (5 mM) was large
enough to ensure virtually complete membrane binding of penetratin, which
was conﬁrmed by tryptophan ﬂuorescence titration experiments (data not
shown). In addition, no differences in the ﬂuorescence and circular
dichroism spectra could be observed between samples with penetratin
added before and after vesicle formation, respectively, suggesting similar
locations of the peptide in the membrane (data not shown).
Dialysis
Dialysis experiments were performed using Spectra/Por Float-A-Lyzer tubes
(Carl Roth, Karlsruhe, Germany) with a volume of 500 mL and a molecular-
weight cutoff of 3 3 105. The dialysis tubes were ﬁlled with samples con-
sisting of, respectively, 25 mM pure penetratin in phosphate buffer, 25 mM
penetratin added externally to 5 mM SUVs or LUVs, and 5 mM vesicles
preloaded with a total of 25 mM peptide on both leaﬂets. Each tube was
placed in a covered glass beaker ﬁlled with 500 mL buffer, which was
replaced every 24 h, and continuously stirred at room temperature for 96 h to
attain equilibrium. Differences in peptide concentration upon dialysis were
determined by ultraviolet absorbance at 280 nm on a V-550 UV-vis spec-
trometer (Jasco, Tokyo, Japan) with 1-mm quartz cuvettes (Hellma) and by
intrinsic tryptophan ﬂuorescence emission at 300–500 nm upon excitation at
280 nm on a JASCO FP-6500 ﬂuorescence spectrometer using 1-cm2 quartz
cuvettes from Hellma. Absorbance values and ﬂuorescence spectra obtained
from pure buffer or from 5 mM lipid suspensions without penetratin were
subtracted from the corresponding raw data.
RESULTS
Confocal laser scanning microscopy
Translocation of penetratin across the bilayers of giant vesi-
cles was studied by confocal laser scanning microscopy.
Fig. 1, A–F, shows CLSM images taken in the equator plane
of lipid particles from the same batch containing 200 mM
FIGURE 1 Confocal laser scanning microscopy on giant vesicles com-
posed of POPC/POPG (3:1 mol/mol) and labeled with 0.0061 mol % Rh-
DPPE. The images were taken between 5 min and 4 h after addition of 5 mM
CF-penetratin to 200 mM lipid. (A–C) Rhodamine ﬂuorescence from lipidic
structures was excited at 543 nm and registered above 560 nm. (D–F)
Carboxyﬂuorescein ﬂuorescence was excited at 488 nm and monitored
at 505–530 nm. (G) The proﬁle depicts the ﬂuorescence intensities, I, from
Rh-DPPE (red line) and CF-penetratin (green line) along the arrow in
the equator plane of the vesicle in A and D.
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POPC/POPG (3:1 mol/mol) GVs ﬂuorescently labeled with
0.0061 mol % Rh-DPPE in the presence of 5 mM CF-
penetratin. The simultaneous use of rhodamine-marked lipid
and carboxyﬂuorescein-labeled peptide allowed for the in-
dependent observation of vesicular structures (Fig. 1, A–C)
and penetratin distribution (Fig. 1, D–F) in the same sample.
From the rhodamine emission images, it is obvious that the
spontaneous-formation method led to a variety of different
lipid aggregates. Whereas the particle in Fig. 1 A seems to be
a simple unilamellar vesicle surrounding an aqueous interior
(see Table 1), dense vesicular structures are found in the
lumen of the vesicle in Fig. 1 B, and the particle in Fig. 1 C
appears to consist largely of lipidic components.
The strong membrane afﬁnity of penetratin is visualized in
Fig. 1D, where an intense CF-penetratin signal emerges from
the bilayer but not from the aqueous solutions outside and
inside. This is corroborated by the intensity proﬁle in
Fig. 1G along a projection line through the equator (arrow in
Fig. 1, A and D). Note that the ﬂuorescence intensity of
;25 au observed in the aqueous medium inside the vesicle
corresponds to the background signal obtained for a peptide-
free liposome suspension and, as such, cannot serve as
a measure of penetratin translocation. Interestingly, how-
ever, CF-penetratin did not accumulate on the surface of the
particles contained in the lumina of the vesicles in Fig. 1, E
and F, even after several hours, implying that the latter
constituted a tight seal not to be overcome by the peptide. On
the other hand, we also observed a few (,5%) vesicles with
membrane defects and signiﬁcant intravesicular CF ﬂuores-
cence (data not shown, see Discussion, below).
Confocal ﬂuorescence spectroscopy
To assess the inﬂuence of membrane curvature and voltage
on penetratin transport, we performed translocation experi-
ments on planar lipid bilayers in the absence and in the pres-
ence of an external transmembrane electric potential difference.
To this end, a negatively charged black membrane composed
of DPhPC/DPhPS (3:1 mol/mol) was prepared, across which
a voltage of Df ¼ 100 mV was applied. Fig. 2 illustrates
a ﬂuorescence intensity z-scan taken 10 min after injection of
1 mM CF-penetratin into the upper compartment (z . 0),
which exhibited a signiﬁcant signal due to ﬂuorescent
molecules dissolved in the aqueous phase (solid line). The
high ﬂuorescence intensity at the position of the lipid bilayer
(z ¼ 0) pointed to strong peptide accumulation at the black
membrane, whereas no CF-penetratin could be detected in
the lower chamber (z , 0). The autocorrelation function,
G(t), recorded 25 mm above the bilayer after 10 min (data
not shown) was ﬁtted with Eq. 1, yielding a diffusion time of
tD¼ 61 ms and a mean number of ﬂuorescent particles in the
confocal volume (0.7 fL) of N ¼ 190, which corresponds to
a ﬂuorophore concentration of 0.45 mM. Thus, the peptide
concentration in the upper chamber was reduced by a factor
of ;2 during the ﬁrst 10 min and further decreased to
0.36 mM after 2 h (dashed line). However, the loss of CF-
penetratin in the upper chamber was not accompanied by
an intensity gain in the lower compartment and can be ex-
plained by peptide adsorption to the Teﬂon walls of the
sample chamber (see Discussion, below). Consequently, no
autocorrelation functions could be obtained for the lower
compartment. Comparable results indicative of the inability
of penetratin to cross planar bilayers were obtained in the
absence of an external transmembrane potential (data not
shown).
As a positive control, ﬂuorescein diacetate was added to
the upper chamber at a ﬁnal concentration of 20 mM (data not
shown). In contrast to CF-penetratin, strong intensities on
TABLE 1 Fluorescence characteristics of rhodamine-labeled
giant vesicles in the presence of CF-penetratin
Vesicle
Panels in
Fig. 1 d (mm) IRh (au) ICF (au) I
out
CF ðauÞ IinCFðauÞ
1 A/D 50 90 100 44 25
2 B/E 97 250 90 40 21
3 C/F 59 250* 70 40 25
4 — 46 80 100 39 25
5 — 72 160 100 50 29
Summarized are the results obtained for ﬁve giant vesicles, three of which
are shown in Fig. 1, A–F. d stands for the vesicle diameter. IRh and ICF are
the mean values of, respectively, the rhodamine and the carboxyﬂuorescein
ﬂuorescence intensities measured in a 1-mm segment enclosing the
membrane along the arrow through vesicle 1 in Fig. 1, A and D. IoutCF and
IinCF denote the mean intensities obtained from a 5-mm segment along the
same line outside and inside the vesicle, respectively.
*250 au was the upper limit for quantiﬁcation of ﬂuorescence intensity. See
Fig. 1 for experimental conditions.
FIGURE 2 Mean ﬂuorescence intensity, I, along a z-scan through two
compartments separated by a black membrane (z ¼ 0) consisting of DPhPC/
DPhPS (3:1 mol/mol) in the presence of a transmembrane potential of Df[
ft –fc¼100 mV. The proﬁles were recorded at 10 min (solid line) and 2 h
(dotted line), respectively, after addition of 1 mMCF-penetratin to the upper
chamber (z . 0).
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both sides of the black membrane after 10 min pointed to the
presence of the ﬂuorescent hydrolysis product ﬂuorescein in
the upper as well as in the lower compartment. As indicated
by an increase in the mean ﬂuorescence signal and a con-
comitant decrease in the corresponding autocorrelation
amplitude, the concentration of the ﬂuorescent analog in
the lower chamber rose for up to 35 min after the start of the
experiment because of progressive hydrolysis of bilayer-
permeant ﬂuorescein diacetate. For both CF-penetratin and
ﬂuorescein, the absence of an electric current between the two
chambers demonstrated that the membranes were not dis-
rupted during the experiments.
Dialysis
Unlike giant vesicles and planar black membranes, small and
large unilamellar vesicles with diameters of, respectively,
;30 nm and ;100 nm exhibit strong bilayer curvature. We
developed a novel dialysis method for the facile monitoring
of transbilayer movement in SUVs and LUVs. Fig. 3 A de-
picts absorbance values measured for three different solu-
tions before (shaded bars) and after (solid bars) dialysis
during 96 h. Sample 1 contained 25 mM penetratin only;
sample 2 contained 25 mM peptide added externally to 5 mM
SUVs composed of POPC/POPG (3:1 mol/mol); and sample
3 contained 5 mM lipid vesicles uniformly preloaded with
25 mM penetratin. Absorbance was virtually completely lost
upon dialysis of samples 1 and 2 because the peptide was not
hindered from diffusing through the large pores of the
dialysis tubes (molecular-weight cutoff 3 3 105). In stark
contrast to this,;40% of the initial signal was retained in the
case of sample 3. Given that 30-nm SUVs have only ;40%
of their lipid molecules in the inner leaﬂet and that the pep-
tide was fully membrane-bound during vesicle formation,
this implies that penetratin could not signiﬁcantly overcome
the lipid bilayer despite the prolonged dialysis time.
A more thorough determination of peptide translocation
was possible with ﬂuorescence spectroscopy, as shown in
Fig. 3 B. Upon irradiation at 280 nm, pure penetratin in
sample 1 (shaded line) displayed a strong peak at 355 nm
indicative of a hydrophilic environment of the two tryp-
tophan residues, which was lost during dialysis (solid line).
The blue shift to 345 nm and the intensity gain found for
peptide added externally to lipid vesicles in sample 2 (shaded
dashed line) pointed to a more hydrophobic tryptophan en-
vironment because of membrane adsorption. However, pep-
tide desorption and dilution during dialysis lowered the signal
to a value near zero (solid dashed line). On the contrary,
the ﬂuorescence intensity of sample 3 (shaded dotted line)
containing peptide-preloaded vesicles was not reduced below
;40% (solid dotted line), which is in good accord with
the absorbance experiments. Similar results were obtained
with LUVs, but the fraction of retained penetratin was raised
to ;50% owing to the larger vesicle diameter (data not
shown).
DISCUSSION
Giant vesicles as model systems for
translocation studies
The confocal laser scanning microscopy images presented in
Fig. 1, A–F, provide evidence that penetratin is not able to
translocate across the negatively charged lipid bilayers of
giant vesicles under the conditions used in this work.
Previous studies on membrane permeability to penetratin
have yielded conﬂicting results, which has been ascribed to
differences in experimental conditions, notably in membrane
curvature and transbilayer voltage. Our observations are in
accordance with accounts reporting no entry of penetratin
into SUVs (15) or LUVs (16,18) composed of mixtures of
negatively charged and neutral phospholipids in the absence
of a transmembrane voltage. However, they are at odds with
FIGURE 3 Dialysis with a molecular-weight cutoff of 33 105 for 96 h of
25 mM penetratin and 5 mM small unilamellar vesicles composed of POPC/
POPG (3:1 mol/mol). (A) The absorbance at 280 nm, A, was taken before
(shaded bars) and after (solid bars) dialysis of samples initially containing
only penetratin (1), penetratin added externally to SUVs (2), or penetratin
distributed over both membrane leaﬂets (3). (B) Irradiation at 280 nm
yielded the ﬂuorescence intensity, F, before and after dialysis of penetratin
(shaded and solid line, respectively), penetratin on the outside of SUVs
(shaded dashed and solid line, respectively), or penetratin on both vesicle
leaﬂets (shaded dotted and solid line, respectively).
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an early publication claiming the direct visualization by CLSM
of penetratin uptake into GVs (8).
In contrast to these authors, we could monitor both lipidic
structures and penetratin distribution independently in the
same sample owing to the simultaneous but differentiable
labeling with rhodamine and carboxyﬂuorescein, respec-
tively. The lamellarities of the giant vesicles can thus be
deduced from the Rh-DPPE ﬂuorescence intensities (20),
which are listed in Table 1 for ﬁve representative GVs. Com-
pared with the least ﬂuorescent membranes of vesicles 1
(Fig. 1 A) and 4, the ﬂuorescence levels of vesicles 2
(Fig. 1 B) and 5 were elevated by factors of 3 and 2,
respectively. Nevertheless, the ﬂuorescence intensities
resulting from the excitation of CF-labeled peptide bound
to the surface of the undamaged lipid particles 1–5 were
independent of vesicle lamellarity.
Importantly, spontaneous self-organization of lipids results
in many different types of liposomes and vesicle clumps
(16,20), whosemembranes are easily disrupted and reannealed
in response to mechanic stress even after the addition of
peptide (26). The fact that giant vesicles are better comparable
in size to live cells than smaller vesicular aggregates should
not overshadow that cellular membranes, unlike GVs, are
supported by a complex and sophisticated scaffold. Hence,
transient membrane disruption might allow free diffusion of
penetratin within the aqueous phase without need for trans-
ferring the charged peptide across the hydrophobic bilayer
core. In fact, we found that a small fraction of the GVs con-
tained penetratin-coated lipid assemblies within their lumen,
and this fraction was considerably raised upon vigorous
agitation of the sample (data not shown). However, the ob-
servation that most vesicles did not permit intravesicular
peptide accumulation and exhibited the same CF-penetratin
ﬂuorescence intensity on their surface regardless of their
lamellarity argues against direct permeation across the lipid
bilayer, and instead calls for careful handling ofGV solutions.
Inﬂuence of a transmembrane voltage
It has been suggested that penetratin (18) and also some
positively charged mitochondrial presequences (27) trans-
locate across lipid bilayers only in the presence of a large
transmembrane electric potential difference. Unlike assays
based on the activity of valinomycin (18), black lipid mem-
brane studies enable direct voltage generation without re-
quiring ionophores. Upon application of a transbilayer
potential difference, Df, the diffusive ﬂow of an ion across
a unit area of a membrane, J, is expected to augment (28)
according to
JðDf 6¼ 0Þ ¼ a 1
1 ea
c
i
ce
a  cit
c
i
c  cit
JðDf ¼ 0Þ; (2)
where cic and c
i
t denote the interfacial aqueous ion con-
centrations on the cis and trans sides, respectively (see
below), and a [ znomeDf/kT comprises the nominal charge
number, znom; the electronic charge, e; the Boltzmann con-
stant, k; and the absolute temperature, T. For cic  cit; znom¼
7, T ¼ 298 K, and for potential differences Df , 20 mV,
Eq. 2 simpliﬁes to
JðDf 6¼ 0Þ ¼ znomeDf
kT
JðDf ¼ 0Þ: (3)
Thus, the ﬂow increases linearly with the transmembrane
voltage and, for znom ¼ 7 in the present case, amounts to
J(Df ¼ 100 mV) ¼ 27 3 J(Df ¼ 0). Taking into account
an effective charge number of zeff ¼ 5 (29) would further
lower this value, implying that the potential difference raises
the diffusive permeability of the lipid membrane by only one
order of magnitude. In fact, applying confocal ﬂuorescence
spectroscopy to a planar bilayer exposed to Df¼100 mV,
we found no corroboration of voltage-induced transbilayer
transport of penetratin.
A rough estimate of the sensitivity of this approach may be
gained in terms of the membrane permeability coefﬁcient, P,
which is deﬁned as
P [
J
c
i
c  cit
; (4)
with cic and c
i
t being the penetratin concentrations in the
interfacial aqueous phases in immediate vicinity of the
membrane on the cis and trans sides of the black lipid
membrane, respectively. In general, these values differ from
the corresponding bulk concentrations because of electro-
static attraction of the positively charged peptide to the
negatively charged membrane. Based on an effective charge
number of zeff ¼ 5 and a mole ratio partition coefﬁcient of
K ¼ 80 L/mol (see Ref. 29, which is in good agreement with
calorimetric data not shown here), cic can be calculated with
the aid of Gouy-Chapman theory to amount to ;200 mM,
whereas cit remains negligible. The ﬂow of Dn moles of
solute across the membrane area A within the time-span Dt is
obtained as
J [
1
A
Dn
Dt
¼ Vt
pr
2
Dct
Dt
; (5)
where r is the radius of the hole in the PTFE septum
(;75 mm), Vt the volume of the lower chamber (2 mL), and
Dct the difference in bulk peptide concentration in the
lower compartment between the ﬁrst (t ¼ 10 min) and the
last (t ¼ 120 min) measurement. Inserting Eq. 5 into Eq. 4
yields for the membrane permeability coefﬁcient
P ¼ Vt
pr
2
c
i
c
Dct
Dt
: (6)
Because Dct was undetectably low, the high sensitivity of
confocal ﬂuorescence spectroscopy imposes Dct  1 nM,
such that the membrane permeability coefﬁcient is estimated
to amount to P  107 m/s (see also following section).
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In the above considerations, the contribution to the transmem-
brane potential difference arising from partial compensation
of the surface charge by asymmetric penetratin adsorption
was not taken into account. However, values of zeff ¼ 5 and
K¼ 80 L/mol (29) predict that the additional transmembrane
potential difference cannot exceed 20 mV under the
conditions used here and may thus be neglected. Moreover,
lipid membranes readily rupture at transmembrane voltages
Df  100 mV, which was not borne out experimentally.
Much more drastic transbilayer electric ﬁeld strengths upon
asymmetric penetratin adsorption have been suggested to
impair membrane stability and permit peptide translocation
(17). As reported by these authors, however, the critical
threshold of membrane-bound penetratin for this mechanism
to be active would necessitate both an elevated percentage
(;50 mol %) of negatively charged lipid headgroups and
a high peptide concentration. Since our experiments were
conducted with less highly charged membranes, they do not
allow for a conﬁrmation of this electroporation-like phe-
nomenon, but the signiﬁcance of the latter for the in vivo
mode of cellular internalization seems questionable.
Hence, the reduction in the CF-penetratin concentration in
the cis compartment and at the position of the negatively
charged membrane was not due to bilayer permeation be-
cause no concomitant rise in concentration was detectable on
the trans side. Rather, peptide adsorption to the Teﬂon walls
of the measuring chamber is at the root of this effect, as has
recently been demonstrated for a number of various surfaces
(29–31).
Dialysis for determining membrane permeability
Area imbalance between the inner and the outer leaﬂet of
a lipid bilayer has been considered an important determinant
in transmembrane transport (16). Because giant vesicles and
black membranes have only negligible or no net membrane
curvature, respectively, we employed small and large uni-
lamellar vesicles as model systems with pronounced curvature
stress. Even though SUVs and LUVs are well-characterized
tools of great usefulness for numerous biophysical and bio-
chemical assays, transbilayer movement is more difﬁcult to
monitor than with GVs or black lipid membranes because the
cis and the trans bilayer sides of the former are not ob-
servable independently or separable macroscopically. Pro-
tocols for assessing membrane translocation therefore often
depend on the spectroscopic or isotopic labeling of lipids,
peptides, or both (15,16). We aimed at establishing a straight-
forward permeability assay based on an approach originally
developed for microcalorimetric studies (32). In contrast to
the latter, the present dialysis procedure does not yield a
detailed thermodynamic description of the membrane adsorp-
tion process but, in exchange, is applicable also to systems
for which no such thermodynamic data are available. In
addition, it is, in principle, amenable to a broad spectrum of
different detection methods, such as ﬂuorescence, absor-
bance, circular dichroism, nuclear magnetic resonance, or
biochemical assays, and also allows for kinetic data to be
derived. Apart from a suitable signal, the sole requirements
are that the fraction of initially membrane-bound solute be
known, in the simplest case that binding be complete, that
the solute suffer no harm during the sometimes harsh treat-
ment necessary for producing liposomes, and that its in-
teractions with the lipid bilayer do not depend on whether it
is added before or after vesicle preparation.
The permeability coefﬁcient is again given by Eq. 4, where
cic and c
i
t denote the interfacial aqueous penetratin concen-
trations inside (cis) and outside (trans) the vesicle, re-
spectively. Whereas cit vanishes during dialysis, c
i
c remains
virtually constant in the present case. With Rb [ cb/cl being
the ratio of the concentration of membrane-bound penetratin,
cb, to the lipid concentration, cl, a partition equilibrium based
on Rb ¼ Kcic provides
cic ¼
Rb
K
¼ 1
K
cb
cl
; cit ¼ 0: (7)
A lipid concentration of cl ¼ 5 mM is high enough to
ensure almost complete binding of the peptide during vesicle
preparation, such that cb  25 mM. The ﬂow, J, can be cal-
culated on the basis of the approximation that the membrane
area, A, of nl moles of lipid with a molecular surface area
requirement of Al is given by A ¼ NAnlAl/2, with NA
denoting Avogadro’s number. Thus,
J [
1
A
Dn
Dt
¼ 2
NAclAl
Dc
Dt
; (8)
where Dn and Dc stand for, respectively, the molar amount
and the concentration of penetratin that crosses the mem-
brane within the time-span Dt. Inserting Eqs. 7 and 8 into Eq.
4 yields
P ¼ 2K
NAcbAl
Dc
Dt
: (9)
Assuming that the spectroscopic methods employed here
are sensitive enough to reduce the error in determining the
peptide concentration to ,10% with respect to the initial
value, Dc , 2.5 mM represents the upper limit of the pen-
etratin concentration lost by permeation during dialysis. For
K¼ 80 L/mol (29), Al¼ 0.7 nm2, and Dt¼ 96 h, we obtain a
maximum value of P , 1013 m/s, which is still 2–3 orders
of magnitude lower than the permeability coefﬁcients
determined for halide anions (33).
CONCLUSIONS
The present work conﬁrms the high afﬁnity of penetratin to
negatively charged phospholipid bilayers (29,34). The weak
blue shift of the tryptophan emission spectrum from
;355 nm in aqueous buffer to ;345 nm in an excess of
POPC/POPG (3:1 mol/mol) vesicles points to superﬁcial
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adsorption of the peptide rather than deep bilayer penetra-
tion, which is in agreement with previous studies (35,36).
However, we found no evidence of translocation across the
bilayers of planar membranes or small, large, and giant
vesicles under the conditions used here. These data strongly
question observations of penetratin uptake into giant vesicles
(8) but are in line with recent studies demonstrating
artifactual internalization in vitro (10,11). Similar results
have been obtained with different methods for other cationic
CPPs, such as TAT (37). Thus, the ability to overcome a lipid
bilayer seems to be restricted to a small yet diverse group of
peptides including the bee venom melittin (38) and
antimicrobial peptides like magainin 2 (39) and buforin 2
(40). On the contrary, penetratin and many other highly
charged nonlytic CPPs most likely enter living cells by
a mainly endocytotic pathway (12–14), which might be
initiated by electrostatic accumulation of the peptides at
negatively charged membrane constituents, such as lipid
headgroups or heparan sulfate proteoglycans (41–43).
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